Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
CRMD
$7.54
-7.37%
CRMD · CorMedix Inc.
$7.54
-0.60 (-7.37%)
At close · Aug 14
Market Cap
$587.70M
Shares
77.94M
All earnings calls
Earnings call · FY2026 Q2
CorMedix Inc. Q2 FY2026 Earnings Call
CorMedix Inc. Q2 FY2026 Earnings Call
Forward guidance
3 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$101.93M
+156.5% YoY
Diluted EPS
$0.29
+3.6% YoY
Gross margin
75.7%
-19.6 pp YoY
Net income
$25.99M
+31.1% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 13, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Consolidated revenue
Initiated
full-year 2026
|
$325M – $345M | — | |
|
Adjusted EBITDA
Initiated
full-year 2026
|
$125M – $140M | Non-GAAP | |
|
Cash OpEx
Initiated
full-year 2026
|
$145M – $155M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 13, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 13, 2026 · complete as-filed document